Meng‐Ling Wu

机构：Oklahoma Medical Research Foundation · ORCID：0000-0002-2916-512X

发表论文 54 篇 · 总被引 1751 次 · h-index 19

代表论文

• The Influence of Exercise on Cancer Risk, the Tumor Microenvironment and the Treatment of Cancer (2024 · Sports Medicine · 被引 23)
• A Polymer-Based Antigen Carrier Activates Two Innate Immune Pathways for Adjuvant-Free Subunit Vaccines (2024 · ACS Nano · 被引 23)
• Cytokine-Mediated Degradation of the Transcription Factor ERG Impacts the Pulmonary Vascular Response to Systemic Inflammatory Challenge (2023 · Arteriosclerosis Thrombosis and Vascular Biology · 被引 22)
• Barcoded screening identifies nanocarriers for protein delivery to kidney (2025 · Nature Communications · 被引 20)
• A Biodegradable Antigen Nanocapsule Promotes Anti‐Tumor Immunity via the cGAS‐STING Pathway (2023 · Advanced Functional Materials · 被引 14)
• OSW-1 induces apoptosis and cyto-protective autophagy, and synergizes with chemotherapy on triple negative breast cancer metastasis (2022 · Cellular Oncology · 被引 11)